Fathy Ahmed Nada
Biographic Data
| ID | 8422233 |
|---|---|
| NAME | Fathy Ahmed Nada |
| GIVEN NAMES | Fathy Ahmed |
| FAMILY NAME | Nada |
| SIGNATURE | NADA F A |
| AFFILIATIONS | Al-Azhar University |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
The correlation of ABMP and RV dysfunction detected by speckle tracing in obese hypertensive patients
Background: Obesity significantly raises the risk of high blood pressure as well as heart conditions. Ambulatory blood pressure monitoring (ABPM) is a reliable way to diagnose and manage hypertension, providing more accurate predictions for cardiovascular results than standard office readings. Right ventricular (RV) dysfunction, evaluated using speckle tracking echocardiography, is becoming a new indicator of cardiovascular risk. Objective: To in…
The role of dapagliflozin in reducing anthracycline-induced cardiotoxicity in type 2 diabetes mellitus patients with breast cancer
Background: Anthracyclines are a cornerstone of breast cancer treatment but are associated with significant cardiotoxicity, particularly in patients with pre-existing conditions such as type 2 diabetes mellitus (T2DM). Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has shown potential cardioprotective effects. This study investigates whether dapagliflozin can delay the progression of anthracycline-induced cardiotoxicity in T2D…
No prominent works on this page.
The correlation of ABMP and RV dysfunction detected by speckle tracing in obese hypertensive patients
Background: Obesity significantly raises the risk of high blood pressure as well as heart conditions. Ambulatory blood pressure monitoring (ABPM) is a reliable way to diagnose and manage hypertension, providing more accurate predictions for cardiovascular results than standard office readings. Right ventricular (RV) dysfunction, evaluated using speckle tracking echocardiography, is becoming a new indicator of cardiovascular risk. Objective: To in…
The role of dapagliflozin in reducing anthracycline-induced cardiotoxicity in type 2 diabetes mellitus patients with breast cancer
Background: Anthracyclines are a cornerstone of breast cancer treatment but are associated with significant cardiotoxicity, particularly in patients with pre-existing conditions such as type 2 diabetes mellitus (T2DM). Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has shown potential cardioprotective effects. This study investigates whether dapagliflozin can delay the progression of anthracycline-induced cardiotoxicity in T2D…
Internal Medicine (2 works) · Medicine (2 works) · Anthracycline (1 works) · Artificial Intelligence (1 works) · Breast cancer (1 works) · Cancer (1 works) · Cardiology (1 works) · Cardiotoxicity (1 works) · Cardiovascular Health and Disease Prevention (1 works) · Chemotherapy (1 works)